These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 59850

  • 1. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R, TEYCHENNE P, Gillespie MM, Perlow M, Gielen AC, Sadowsky DA, Calne DB.
    Lancet; 1976 Aug 07; 2(7980):272-5. PubMed ID: 59850
    [Abstract] [Full Text] [Related]

  • 2. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I, Gawel MJ, Riopelle RJ, Bouchard S.
    Can J Neurol Sci; 1987 Nov 07; 14(4):576-80. PubMed ID: 3319120
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr 07; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
    Lipper S.
    Lancet; 1976 Sep 11; 2(7985):571-2. PubMed ID: 60643
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
    Hely MA, Morris JG, Reid WG, O'Sullivan DJ, Williamson PM, Rail D, Broe GA, Margrie S.
    J Neurol Neurosurg Psychiatry; 1994 Aug 11; 57(8):903-10. PubMed ID: 8057111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Lieberman A, Goodgold A, Jonas S, Leibowitz M.
    Neurology; 1975 Oct 11; 25(10):911-6. PubMed ID: 1101099
    [Abstract] [Full Text] [Related]

  • 20. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
    Savery F.
    Dis Nerv Syst; 1977 Aug 11; 38(8):605-8. PubMed ID: 328244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.